Skip to content

A Clinical study to know the benefit of kantakaryadi kwath and patoladi kwath in treatment of amlapitta with reference to hyperacidity

A comparative clinical study of kantakaryadi kwath with patoladi kwath in the management of urdhwaga amlapitta with special reference to gastro oesophageal reflux disease - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086331
Enrollment
40
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis

Interventions

None listed

Sponsors

Abhishek Suresh Kolhe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having lakshanas of urdhwaga amlapitta

Exclusion criteria

Exclusion criteria: pregnant women lactating mothers patient with severe vomiting and diarrhea patient who cant take medicines orally amlapitta with other chronic diseases

Design outcomes

Primary

MeasureTime frame
headache nausea reducedTimepoint: after 7 days

Secondary

MeasureTime frame
improvement in heartburn loss of taste blenching throat irritationTimepoint: after 15 days

Countries

India

Contacts

Public ContactAbhishek Suresh Kolhe

Shri Shivayoogeshwar Rural Ayurvedic College and Hospital

dr.ishwar.mathapati@gmail.com7259779463

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026